DRIVING THE FUTURE WITH BIOKANSAS

Access to Research and infrastructure: The Contract Research Industry

Register

About

The Event

April 27-28, 2023  |  8:00 am – 5:00 pm (central time)

This event features industry leaders that provide a detailed exploration of the intricate contract research market.

Join the symposium to:

 

  • Ask direct questions of and connect with industry leaders
  • Understand the CRO market and growth opportunities
  • Explore the impact of CRO consolidation and customer concentration
  • Learn about new and emerging regulations that impact drug development
  • Meet CRO executives and learn about their company’s services and expertise
  • Identify tools and technologies that aid in advancing the CRO industry
  • And more!

Attendees also have the opportunity to visit contract research laboratories in Kansas City.

Registration Costs

 

Early Registration BioKansas Members – $150 (until February 28)

Early Registration Non-BioKansas Members  – $200 (until February 28)

 

Regular Registration BioKansas Members – $200

Regular Registration Non-BioKansas Members – $250

 

Onsite Registration – $290

Register
Become A Sponsor

Meet the Speakers

John Bucksath

Chief Executive Officer | Integris BioServices dba KCAS

Brandon Clough

Chief Revenue Officer | PSC Biotech and PSC Software

Andrea Bradley Ewing

Senior Director of Community Engaged Research | Children’s Mercy, Kansas City

Kyle Kappler

Senior Consultant of Discovery, Nonclinical, and Animal Health | Latham BioPharm Group

Amy Mize

Sr.Vice President Business Development | KCAS Bioanalytical and Biomarker Services

Dr. James Randazoo, PhD, DABT

Director of Toxicology | Attentive Science

Jonathan White

Director, Pharmaceutical Sciences | MRIGlobal

Phillip Beske, PhD, DABT

Director, Medical Research | MRIGlobal

Cartier Esham, PhD

Chief Scientific Officer | Biotechnology Innovation Organization

Michelle Fosler

Technical Sales Specialist - ADME Tox | XenoTech a BioIVT company

Christine Lee

Office of Minority Health and Health Equity (OMHHE) in the Office of the Commissioner | U.S. Food and Drug Administration

Justin Mutzbauer

Executive Producer, Business Insurance Healthcare | Life Sciences Practice Marsh McLennan Agency

Crissa Cook

Patent Attorney | Hovey Williams

Mark Wissel, PhD

Director, R&D | Eurofins Viracor BioPharma Services

Dr. Mario Castro, MD, MPH

L. E. Phillips and Lenora Carr Phillips Professor Chief, Pulmonary, Critical Care and Sleep Medicine Vice Chair for Clinical and Translational Research Director, Frontiers Clinical and Translational Science Institute at the University of Kansas

Karina Eterovic

R&D Director for Oncology and Sequencing | Eurofins-Viracor

Robert Hunter

Chief Science and Regulatory Officer | Veterinary Health Research Centers

Matthew McClorey

President | CritiTech Particle Engineering Solutions

Stephanie Pasas-Farmer, PhD

President and Principal Consultant | BioData Solutions, LLC President and Founder | Ariadne Software, LLC

Greg Slaybaugh

Director, CQV | Arcadis DPS Group

Greg Slaybaugh

Director, CQV | Arcadis DPS Group

Event Moderators

Sonia Hall

President & CEO BioKansas

DJ Rezac

Senior Consultant Latham Biopharm Group

Agenda

Thursday

8:30-9:00 am

Registration

Location: Kansas State University – Olathe

22201 W Innovation Drive

Olathe, KS 66061

9:00-9:30 am

Keynote

The CRO Investment Market: Keeping up with an ever evolving services business model serving the biotech and pharmaceutical industries

  • John Bucksath

9:30 am

A Buyers Guide for Navigating the Current Contract Research Organization Landscape

  • Kyle Kappler

10:00 am

Regulated PCR and Biologics Trial Support

  • Mark Wissel, PhD

10:15 am

Cybersecurity State of the Market

  • Justin Mutzbauer

10:30 am

Maximizing IP Value: Tips and Best Practices for CROs in R&D Collaboration

  • Crissa Cook

10:45-11:15 am

Coffee & Collaboration

11:15 am – 12:00 pm

Panel Discussion

Advancing Business Objectives In A Changing Market

  • Moderator: DJ Rezac

12:00-1:15 pm

Lunch & Networking

1:15 pm

Considerations for Formulation Development and Analysis in Preclinical Toxicology Studies

 

  • Dr. James Randazoo, PhD, DABT

1:30 pm

Veterinary Health Research Centers, Real World Data

  • Robert Hunter

1:45 pm

Exploring the Application of NGS (Next Generation Sequencing) and Other Molecular Tools in Oncology Clinical Testing and Drug Development

  • Karina Eterovic

2:00 pm

 Advancing drug development with high quality, science-first, client centric culture at KCAS

  • Amy Mize

2:15 pm

CritiTech Particle Engineering Solutions – A Multiservice CDMO Providing POC to GMP Drug Development, Manufacturing and Analytical Services & Solving Formulation Challenges Through Particle Engineering

  • Matthew McClorey

2:30 pm

CRO support for toxicology and medical countermeasure development

  • Phillip Beske, PhD, DABT

3:00-4:30 pm

Networking Reception

Friday

9:00 am

XenoTech, a BioIVT Company – An Overview of Services

  • Michelle Fosler

9:15 am

Increasing Efficiencies and Impact: The Current State of AI in Pharmaceutical R&D



  • Stephanie Pasas-Farmer

9:30 am

CRO Support for Clinical Trial Materials

  • Jonathan White, PhD

9:45 am

cGMP and Annex I

  • Greg Slaybaugh

10:00 am

Leveraging Innovative Software for Start-ups, MIdsized, and Large Companies

  • Brandon Clough

10:15-10:45 am

Coffee & Connections

10:30-11:00 am

Diversity In Clinical Trials

  • Diversity, Equity, and Inclusion in Pediatric Research
  • Andrea Bradley Ewing

11:00-11:45 am

Diversity In Clinical Trials Panel Discussion

  • Moderator: Andrea Bradley Ewing
  • Dr. Mario Castro
  • Dr. Cartier Esham
  • Dr. Christine Lee

11:45 am – 12:45 pm

Lunch

1:00-4:00 pm

Facility Tours

  • Site 1: KCAS Bioanalytical & Biomarker Services
  • Site 2: Attentive Science
  • Site 3: Eurofins Viracor
  • Site 4: CritiTech Particle Engineering Solutions

Event Sponsors

Vendors

Listen, Share, & Advance Kansas

Register